New Phase 3b Interim Data from STARDUST Study Show TwoThirds of Patients with Moderately to Severely Active Crohns Disease Achieved Clinical Remission After Two Doses of STELARAÂ ustekinumab

First Study to Explore a TreattoTarget Strategy in Crohns Disease using Endoscopy to Guide Dose AdjustmentFirst Study to Evaluate Intestinal Ultrasound Monitoring in an Interventional SettingThe Janssen Pharmaceutical Companies of Johnson & Johnson...